Digital health technologies, AI-driven imaging, and biomarkers are transforming cardiovascular care by facilitating early diagnosis, accurate therapy, and individualized management.
The integration of digital health technologies, AI-driven imaging, and novel biomarkers holds promise for transforming cardiovascular care through precision medicine and early diagnosis.
Cardiovascular diseases (CVDs), the main cause of death worldwide, can only be prevented, diagnosed, and managed more effectively by integrating digital tools, biomarkers, and improved diagnostics. Traditional methods often fail to address the complexity of these diseases; therefore, innovative approaches are required to improve patient outcomes. This review highlights recent developments, clinical consequences, and integration issues as it examines the revolutionary role of digital health technology, biomarkers, and artificial intelligence (AI)-driven imaging in cardiovascular care. A thorough review of the literature focused on cardiovascular biomarkers, imaging techniques, and digital technologies. Modern CVD management revolves around precision medicine, multiomics methods, and AI-driven diagnostics. AI-driven imaging has improved patient classification and diagnostic accuracy. Examples of this include cardiac magnetic resonance imaging and hybrid positron emission tomography/computed tomography. Early identification and risk assessment are facilitated by novel biomarkers, including high-sensitivity troponins and inflammatory markers. Digital technologies, including wearables and telemedicine, enhance patient monitoring and adherence. The personalization of therapy and risk prediction has been greatly enhanced by the combination of AI and machine learning. Digital health technologies, AI-driven imaging, and biomarker integration are transforming cardiovascular care by facilitating early diagnosis, accurate therapy, and individualized management. Nevertheless, for broad acceptance, issues with accessibility, affordability, and ethics must be resolved. Interdisciplinary cooperation should be a key component of future research to guarantee the smooth incorporation of cutting-edge technology into standard clinical practice, which will ultimately improve cardiovascular health outcomes worldwide.
Gupta et al. (Sat,) conducted a review in Cardiovascular diseases. Digital health technologies, AI-driven imaging, and biomarkers was evaluated. Digital health technologies, AI-driven imaging, and biomarkers are transforming cardiovascular care by facilitating early diagnosis, accurate therapy, and individualized management.